Compare BBY & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBY | ALGN |
|---|---|---|
| Founded | 1966 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.0B |
| IPO Year | 1994 | 2000 |
| Metric | BBY | ALGN |
|---|---|---|
| Price | $60.75 | $180.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 11 |
| Target Price | $78.58 | ★ $192.40 |
| AVG Volume (30 Days) | ★ 3.8M | 1.0M |
| Earning Date | 05-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 6.16% | N/A |
| EPS Growth | ★ 17.76 | 0.53 |
| EPS | 5.04 | ★ 5.65 |
| Revenue | ★ $41,691,000,000.00 | $387,126,000.00 |
| Revenue This Year | $1.22 | $5.80 |
| Revenue Next Year | $1.39 | $4.59 |
| P/E Ratio | ★ $12.34 | $30.63 |
| Revenue Growth | 0.39 | ★ 23.95 |
| 52 Week Low | $59.16 | $122.00 |
| 52 Week High | $84.99 | $208.31 |
| Indicator | BBY | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 37.61 | 55.89 |
| Support Level | N/A | $159.99 |
| Resistance Level | $68.68 | $183.34 |
| Average True Range (ATR) | 2.20 | 7.23 |
| MACD | -0.09 | 0.79 |
| Stochastic Oscillator | 14.84 | 80.35 |
With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.